A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research0 sites109 target enrollmentJanuary 2006

ConditionsOpen-angle Glaucoma Ocular Hypertension

InterventionsTravoprost, Investigational Travoprost (TRAVATAN)

DrugsTravoprost, Investigational Travoprost (TRAVATAN)

Overview

Phase: Phase 3
Intervention: Travoprost, Investigational
Conditions: Open-angle Glaucoma
Sponsor: Alcon Research
Enrollment: 109
Primary Endpoint: Mean IOP
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Similar Trials

Overview

Brief Summary

The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Registry

clinicaltrials.gov

Start Date

January 2006

End Date

May 2006

Last Updated

9 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Alcon Research

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Adult patients of either sex of any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.
•Other protocol-defined inclusion criteria may apply.